Long-term Antibiotic Regimens for UTI Prophylaxis

Definition and Impact of Recurrent UTIs

Recurrent UTIs are defined as at least three UTIs per year or two UTIs in the last 6 months, significantly impacting quality of life, affecting social and sexual relationships, self-esteem, and work capacity 1

Increased fluid intake is recommended for premenopausal women 1
Vaginal estrogen replacement is strongly recommended for postmenopausal women 1
Immunoactive prophylaxis is strongly recommended 1
Methenamine hippurate is strongly recommended for women without urinary tract abnormalities 1
Cranberry products have weak evidence with contradictory findings 1, 2
D-mannose has weak evidence 1
Probiotics with proven efficacy for vaginal flora regeneration are recommended 1

Trimethoprim-sulfamethoxazole is recommended at a dose of 40mg/200mg once daily 2, 3
Trimethoprim is recommended at a dose of 100mg once daily 2, 3
Nitrofurantoin macrocrystals are recommended at a dose of 100mg once daily 2, 3
Fosfomycin is recommended to be dosed every 10 days 3
Cephalexin is recommended for daily dosing 2, 3
The standard duration of prophylaxis is 6-12 months 2, 3
Periodic assessment and monitoring are required 3

Post-coital antibiotic prophylaxis is effective and associated with fewer adverse events for UTIs temporally related to sexual activity 3
Self-administered short-term antimicrobial therapy may be considered for patients with good compliance 1

Recurrent UTI should be diagnosed via urine culture (strong recommendation) 1
Routine surveillance urine testing should not be performed in asymptomatic patients 4
Asymptomatic bacteriuria should not be treated 4, 5
Extensive workup (cystoscopy, abdominal ultrasound) is not recommended for women under 40 without risk factors 1

Nitrofurantoin has rare but serious pulmonary (0.001%) and hepatic toxicity (0.0003%) 3
Common adverse effects include gastrointestinal disturbances and skin rash with TMP, TMP-SMX, cephalexin, and fosfomycin 3

Long-term prophylaxis (beyond 1 year) is not evidence-based, though some patients may continue for years without adverse events 3
Antimicrobial stewardship is essential to balance symptom resolution with reducing risk of recurrence 4
The effects of antibiotic prophylaxis last only during the active intake period 2

The standard prophylactic regimen for fosfomycin is administration every 10 days for 6 months, with consideration for discontinuation after this period unless recurrence necessitates continuation, as recommended by the American Urological Association 6
The standard duration of fosfomycin prophylaxis aligns with general antibiotic prophylaxis recommendations of 6-12 months for recurrent UTI, according to the American Urological Association 7

Fosfomycin 3g every 10 days for 6 months resulted in a 95% reduction in UTI episodes, with only 0.14 infections per patient-year compared to 2.97 infections per patient-year with placebo (p<0.001), as demonstrated by the American Urological Association 6

Confirming negative urine culture is essential to document efficacy during fosfomycin prophylaxis, as recommended by the American Urological Association 7

Treatment of asymptomatic bacteriuria increases the risk of symptomatic infection and bacterial resistance, and only symptomatic, culture-confirmed UTIs warrant treatment, according to the Infectious Diseases Society of America 8